Co-Occurrence of Two Cases of Progressive Multifocal Leukoencephalopathy in a Natalizumab “Infusion Group”

Multiple Sclerosis- United States

doi 10.1177/1352458512466165

Full Text

Abstract

Available in

Categories

Date

November 1, 2012

Authors

C Ryschkewitsch

Publisher

SAGE Publications

Related search

Natalizumab-Associated Progressive Multifocal Leukoencephalopathy in Patients With Multiple Sclerosis: A Mini Review

English

Brain Magnetic Susceptibility Changes in Patients With Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

American Journal of Neuroradiology

Nuclear Medicine

English

Progressive Multifocal Leukoencephalopathy

Journal of Multiple Sclerosis

English

Progressive Multifocal Leukoencephalopathy

English

Disease Course and Outcome of 15 Monocentrically Treated Natalizumab-Associated Progressive Multifocal Leukoencephalopathy Patients

Journal of Neurology, Neurosurgery and Psychiatry

English

JC Virus Persistence Following Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients Treated With Natalizumab

Annals of Neurology

English

Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab

English

Progressive Multifocal Leukoencephalopathy: Current Insights

Degenerative Neurological and Neuromuscular Disease

English

Progressive Multifocal Leukoencephalopathy in the Absence of Immunosuppression

Journal of NeuroVirology

Molecular Neuroscience

English